NATCO PHARMA
Back to Income Statement
|
NATCO PHARMA Last 5 Year Profit After Tax History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Profit After Tax | ₹1,388 Cr | ₹715 Cr | ₹170 Cr | ₹442 Cr | ₹458 Cr |
What is the latest Profit After Tax of NATCO PHARMA ?
Year | Profit After Tax |
---|---|
Mar2024 | ₹1,388 Cr |
Mar2023 | ₹715 Cr |
Mar2022 | ₹170 Cr |
Mar2021 | ₹442 Cr |
Mar2020 | ₹458 Cr |
How is Profit After Tax of NATCO PHARMA Trending?
Years | Profit After Tax | % Change | |
---|---|---|---|
Mar2024 | ₹1,388 Cr | 94.09 | |
Mar2023 | ₹715 Cr | 320.76 | |
Mar2022 | ₹170 Cr | -61.57 | |
Mar2021 | ₹442 Cr | -3.43 | |
Mar2020 | ₹458 Cr | - |
Compare Profit After Tax of peers of NATCO PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NATCO PHARMA | ₹15,823.5 Cr | 4.5% | 7.1% | -11.6% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹433,032.0 Cr | 0.9% | 2.2% | 23.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹162,252.0 Cr | 3.3% | 4.7% | 58% | Stock Analytics | |
CIPLA | ₹124,457.0 Cr | 0.5% | 2% | 11.1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹112,425.0 Cr | -0.4% | 2.8% | 24.2% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹98,152.8 Cr | -0.8% | -0.4% | 0.8% | Stock Analytics |
NATCO PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NATCO PHARMA | 4.5% |
7.1% |
-11.6% |
SENSEX | 0.9% |
3% |
8.9% |
You may also like the below Video Courses